EP1214050A1 - Feuchtigkeitsspendende creme zur herstellung des hautgleichgewichts - Google Patents

Feuchtigkeitsspendende creme zur herstellung des hautgleichgewichts

Info

Publication number
EP1214050A1
EP1214050A1 EP00962068A EP00962068A EP1214050A1 EP 1214050 A1 EP1214050 A1 EP 1214050A1 EP 00962068 A EP00962068 A EP 00962068A EP 00962068 A EP00962068 A EP 00962068A EP 1214050 A1 EP1214050 A1 EP 1214050A1
Authority
EP
European Patent Office
Prior art keywords
composition
skin
skin care
acid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00962068A
Other languages
English (en)
French (fr)
Inventor
Anna Louisa Gomes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Research Pty Ltd
Original Assignee
Johnson and Johnson Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Research Pty Ltd filed Critical Johnson and Johnson Research Pty Ltd
Publication of EP1214050A1 publication Critical patent/EP1214050A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents

Definitions

  • the invention relates to a non-comedogenic skin care composition that effectively moisturizes the skin through a combination of the softening effects of emollients with the moisture retaining action of humectants and coating activities of lubricants, to counteract the effect of moisture loss, thereby keeping skin soft, smooth and supple.
  • the invention relates to an oil-free skin care composition for moisturizing the skin comprising:
  • a humectant comprising glycerin and propylene glycol
  • an emollient comprising isohexadecane, cylcomethicone, dimethicone, dimethicone copolyol and trimethylsiloxysilicate; (c) a keratolytic agent; and
  • the skin care compositions according to the invention accomplish effective moisturization through a combination of the softening effects of emollients with the moisture retaining action of humectants and coating activities of lubricants.
  • the combination of ingredients counteract the effect of moisture loss, thereby keeping skin soft, smooth and supple.
  • the compositions according to the invention are non- comedogenic and have long lasting moisturizing effects without the use of occlusive materials.
  • the invention relates to a skin care composition for moisturizing the skin comprising a humectant, an emollient, a keratolytic agent and water.
  • the skin care composition according to the invention is an oil-free, water-based, i.e., oil-in- water emulsion.
  • oil-free means free from petrolatum or any ingredient with the name "oil” in its nomenclature, including, for example, mineral oil.
  • the skin care compositions according to the invention comprise at least one humectant which increases the water content of the top layer of the skin by actively attracting and retaining the moisture where it is needed to relieve dry skin. The skin's moisture level is thereby increased without feeling heavy and occlusive.
  • the humectant is preferably present in an amount of from about 2 to about 10 wt.
  • Suitable humectants for use in the present invention include glycerin, propylene glycol, and mixtures thereof.
  • the humectant is a mixture of from about 1 to about 5 wt.% of glycerin and from about 1 to about 5 wt. % of propylene glycol, even more preferably, from about 2 to about 3 wt. % glycerin and from about 2 to about 3 wt. % propylene glycol, based on the total composition.
  • the skin care composition according to the invention also contain an emollient.
  • the emollient useful in the skin care composition according to the invention contains a mixture of isohexadecane, cyclomethicone, dimethicone, dimethicone copolyol, and trimethylsiloxysilicate.
  • the emollients act indirectly to soften the stratum corneum by slowing down the loss of moisture to the environment, allowing the skin to re- moisturize itself from within.
  • the dimethicone and trimethylsiloxysilicate offers skin protection and long lasting lubricity with a light touch and do not interfere with the skin's transpiration.
  • the combination of cyclomethicone and dimethicone copolyol is normally used for preparing water-in-cyclomethicone emulsions.
  • the cylcomethicone and dimethicone copolyol is used as a delivery system for the emollients. Being a water-based emulsion, i.e., oil-in-water, once applied to the skin, the volatile components evaporate, imparting a cooling effect on the skin as well as leaving behind the heavier, more effective skin conditioning agents on the skin.
  • the dimethicone copolyol is a silicone glycol copolymer that provides humectant benefits in addition to emolliency.
  • Examples of commercially available dimethicone copolyols useful herein sold by Dow Corning Corporation are DC 190, DC 193, DC Q2-5220, DC 2501 Wax, DC 2-5324 fluid, and DC 3225C (this later material being sold as a mixture with cyclomethicone).
  • Cetyl dimethicone copolyol is commercially available as a mixture with polyglyceryl-4 isostearate (and) hexyl laurate and is sold under the tradename ABIL.RTM. WE-09 (available from Goldschmidt).
  • Trimethylsiloxysilicate is a polymeric material corresponding to the general chemical formula [(CH 2 ) 3 SiO 1 2 ] x [SiO 2 ] y , wherein x is an integer from about 1 to about 500 and y is an integer from about 1 to about 500.
  • a preferred commercially available trimethylsiloxysilicate is sold by Dow Corning as a mixture with dimethicone as DC 593.
  • Suitable dimethicones useful as an emollient in the skin care composition of the invention are commercially available from Dow Corning as the Dow Corning 200 series.
  • a particularly preferred dimethicone for use in the skin care compositions of the invention is available from Dow Corning is DC200/350cst.
  • the skin care composition according to the invention comprises from about 3 t about 15 wt.% of the emollient.
  • Particularly preferred is a combination of from about 1.0 to about 4.0 wt.% isohexadecane, from about 1.0 to about 5.0 wt.% of DC 3225C, and from about 0.5 to about 3.0 wt.% of DC 593 and from about 0.5 to about 3.0 DC 200/350 wt.% cst based on the total weight of the composition.
  • the keratolytic agent useful in the skin care compositions according to the invention should be effective in preventing pimples and comodones. Suitable keratolytic agents include alpha hydroxy acids and beta hydroxy acids.
  • the most preferred keratolytic agent is salicylic acid.
  • the keratolytic agent is present in the skin care compositions according to the invention at from about 0.25 to about 2.0 wt.%, more preferably from about 0.5 to about 2.0 wt. %, based on the total composition.
  • the skin care composition according to the invention preferably contains an effective stabilizing amount of an emulsifier.
  • the emulsifier is present at from about 1.0 to about 10.0, more preferably from about 3.0 to about 6.0, weight percent, based on the total composition. Any emulsifier that is compatible with the components of the composition can be employed. However, it has been discovered that when stearic acid is the primary emulsifier, it also helps provide the skin feel of the product. Additionally, when used as co-emulsifiers, cetyl alcohol and stearyl alcohol also provide lubricating properties for the skin.
  • the emulsifier used in the skin care composition of the invention is a mixture of from about 0.5 to about 3.0, more preferably form about 1 to about 2, weight percent, based on the total composition, each of stearic acid, cetyl alcohol and stearyl alcohol.
  • the emulsion can be further stabilized by inclusion of a small quantity of a thickener.
  • the thickener is used in amount of about 0.01 to about 10% by weight based upon the weight of the coating composition. The range of about 0.01 to about 5% by weight is preferred, with the range of about 0.03 to about 1.0% by weight being particularly preferred.
  • the thickener can be a non-associative thickener or stabilizer, such as a homopolymer or a copolymer of an olefinically unsaturated carboxylic acid or anhydride monomers containing at least one activated carbon to carbon olefinic double bond and at least one carboxyl group or an alkali soluble acrylic emulsion.
  • an associative thickener or stabilizer can be used, such as a hydrophobically modified alkali soluble acrylic emulsion or a hydrophobically modified nonionic polyol polymer, i.e., a hydrophobically modified urethane polymer, or combinations thereof.
  • the copolymers are preferably copolymers of a polycarboxylic acid monomer and a hydrophobic monomer.
  • the preferred carboxylic acid is acrylic acid.
  • the homopolymers and copolymers preferably are crosslinked. Homopolymers of polyacrylic acid are described, for example, in U.S. Pat. No.
  • homopolymers examples include Carbopol Registered TM 934, 940, 941, Ultrez 10, ETD 2050, and 974P polymers, which are available from The B. F. Goodrich Company.
  • Such polymers are homopolymers of unsaturated, polymerizable carboxylic monomers such as acrylic acid, methacrylic acid, maleic acid, itaconic acid, maleic anhydride, and the like.
  • Hydrophobically modified polyacrylic acid polymers are described, for example, in U.S. Pat. Nos. and 5,349,030, the disclosures of which are herein incorporated by reference. These polymers have a large water-loving hydrophilic portion (the polyacrylic acid portion) and a smaller oil-loving hydrophobic portion (which can be derived from a long carbon chain acrylate ester).
  • Representative higher alkyl acrylic esters are decycl acrylate, lauryl acrylate, stearyl acrylate, behenyl acrylate and melissyl acrylate, and the corresponding methacrylates.
  • carboxylic monomer and more than one acrylate ester or vinyl ester or ether or styrenic can be used in the monomer charge.
  • the polymers can be dispersed in water and neutralized with base to thicken the aqueous composition, form a gel, or emulsify or suspend a deliverable.
  • Useful polymers are sold as Carbopol Registered TM 1342 and 1382 and Pemulen Registered TM TR-1, TR-2, 1621, and 1622, all available from BFGoodrich. Particularly preferred is Pemulen TR-1 (CTFA Designation: Acrylates/ 10-30 Alkyl Acrylate Crosspolymer).
  • Neutralizing agents suitable for use in neutralizing acidic group containing hydrophilic gelling agents herein include sodium hydroxide, potassium hydroxide, ammonium hydroxide, monoethanolamine, diethanolamine and triethanolamine.
  • the skin care compositions according to the invention preferably has a pH which provides a suitable environment for the keratolytic agent efficacy as well as to maintain the skin's moisture balance where the pH is in the range of 4.5 to 6.5.
  • the pH of the composition ranges from 5.5 to 6.5.
  • the water content of the skin care compositions according to the invention ranges from about 75 to about 85 wt.%, preferably from about 75 to about 80 wt.% water. This relatively high water content makes the cream light and easy to apply.
  • the compositions are preferably formulated so as to have a product viscosity of from about 75,000 to about 300,000 cps.
  • the skin care compositions according to the invention can comprise additional ingredients commonly found in skin care compositions, such as for example, preservatives, antioxidants, perfumes, chelating agents, etc., provided that they are physically and chemically compatible with the other components of the composition.
  • suitable preservatives for use in the skin care compositions of the invention include the C r C 4 alkyl parabens and phenoxyethanol.
  • the preservative is present in an amount ranging from about 0.5 to about 2.0, preferably about 1.0 to about 1.5, weight percent based on the total composition.
  • the preservative is mixture of from about 0.2 to about 0.5 weight percent methylparaben, from about 0.2 to about 5.0 weight percent propylparaben and from about 0.05 to about 0.10 weight percent butylparaben.
  • a particularly preferred commercially available preservative that may be used in the skin care composition according to this invention is PHENONIP TM which is a practically colorless, viscous, liquid mixture of phenoxyethanol, methylparaben, ethylparaben, propylparaben, and butylparaben available from Nipa Laboratories, Inc., Wilmington, Del.
  • an oil-soluble antioxidant should be present in the skin care compositions according to the invention.
  • Suitable antioxidants include butylated hydroxy toluene (BHT), ascorbyl palmitate, butylated hydroanisole (BHA), phenyl-a- naphthylamine, hydroquinone, propyl gallate, nordihydroquiaretic acid, and mixtures thereof.
  • BHT butylated hydroxy toluene
  • BHA butylated hydroanisole
  • phenyl-a- naphthylamine hydroquinone
  • propyl gallate propyl gallate
  • nordihydroquiaretic acid and mixtures thereof.
  • the antioxidant is BHT and is present in the composition at from about .02 to about .05wt%, most preferably from about .02 to about 0.10.
  • Fragrances suitable for use in the skin care compositions according to the invention are well known in the art. Particularly preferred are those that can provide a fruity and/or floral fragrance, such as, for example, Mod Twist, commercially available from Haarmann & Reimer Corp.
  • the compositions should include a chelating agent.
  • Chelating agents which are useful in the compositions of the present invention include ethylenediamine tetra acetic acid (EDTA) and derivatives and salts thereof, dihydroxyethyl glycine, citric acid, tartaric acid, and mixtures thereof.
  • EDTA ethylenediamine tetra acetic acid
  • the chelating agents should be utilized in a stabilizing effective amount and may range from about 0.01 to about 2% based on the weight of the total composition, preferably from about 0.05 to about 1%. Most preferably, the chelating agent should be EDTA.
  • ingredients may include agents which assist in protecting the skin from aging, such as sunscreens, anti-oxidant vitamins such as ascorbic acid, vitamin B, biotin, pantothenic acid, vitamin D, vitamin E and vitamin C, and sodium bisulfite.
  • Yeast extract, gingko biloba, bisabolol, panthenol, alpha hydroxy acids and oligosaccharides such as melibiose are among other ingredients which assist in preventing aging of the skin by such means as irritation mitigation, oxidation mitigation, healing, affecting retinoid metabolism and inhibiting the production of elastase.
  • Ingredients with a low comedogenicity capacity should be chosen in order to render the product non-comedogenic.
  • the skin care compositions according to the invention accomplish effective moisturization through a combination of the softening effects of emollients with the moisture retaining action of humectants and coating activities of lubricants, to counteract the effect of moisture loss, thereby keeping skin soft, smooth and supple.
  • the compositions according to the invention have long lasting moisturizing effects without the use of occlusive materials.
  • compositions of the present invention can be prepared by well-known mixing or blending procedures.
  • Each phase of the emulsion is preferably separately prepared with all of the components contained in the appropriate phase, except that it is usually preferred to omit the retinoid compound initially.
  • the emulsion is then formed normally by adding the oil phase to the water phase with agitation, and the emulsion should be cooled down when the retinoid compound is added.
  • Set forth below is an example of a preferred method for preparing the skin care composition according to the invention.
  • Phase A (main batch)
  • Purified water is added toO mixing vessel.
  • Pemulen TR-1 is sprinkled in and mixed well until dispersed.
  • composition is heated to 70-75 °C whilst mixing. At 70-75°C, Carbopol ultrez 10 is sprinkled in and mixed until dispersed.
  • Isohexadecane is added to a separate vessel followed by cetyl alcohol and heated to 75-80°C, to allow all ingredients to melt.
  • Phasing 15 When the oil phase us at 75-80°C and the water phase is at 70-75°C, the oil phase (phase B) is added to the water phase (phase A) slowly while homogenizing for 5-10 minutes to ensure a homogeneous batch.
  • Triethanolamine is slowly added and mixed for 10 minutes or until a homogenous batch is achieved.
  • Homogenizer is turned off and the composition is mixed and cooled to 40-45°C.
  • Fragrance is added and mixed for 20-25 minutes or until uniform.
  • Viscosity and pH measurement are taken at 25°C.
  • the following example is inteded to illustrate the invention without being limiting in nature.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
EP00962068A 1999-09-09 2000-09-08 Feuchtigkeitsspendende creme zur herstellung des hautgleichgewichts Withdrawn EP1214050A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15300599P 1999-09-09 1999-09-09
US153005P 1999-09-09
PCT/AU2000/001067 WO2001017496A1 (en) 1999-09-09 2000-09-08 Skin-balance moisturizing cream

Publications (1)

Publication Number Publication Date
EP1214050A1 true EP1214050A1 (de) 2002-06-19

Family

ID=22545398

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00962068A Withdrawn EP1214050A1 (de) 1999-09-09 2000-09-08 Feuchtigkeitsspendende creme zur herstellung des hautgleichgewichts

Country Status (9)

Country Link
EP (1) EP1214050A1 (de)
JP (1) JP2003508478A (de)
KR (1) KR20020047153A (de)
CN (1) CN1373654A (de)
AU (1) AU7392900A (de)
BR (1) BR0013874A (de)
CA (1) CA2381560A1 (de)
MX (1) MXPA02002608A (de)
WO (1) WO2001017496A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535373B2 (en) 2004-03-03 2013-09-17 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US10966823B2 (en) 2007-10-12 2021-04-06 Sorin Group Italia S.R.L. Expandable valve prosthesis with sealing mechanism
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6659391B1 (en) 1999-04-30 2003-12-09 Kimberly-Clark Worldwide, Inc. Method for dispensing wet wipes
BR0308051A (pt) * 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
JP4616815B2 (ja) * 2006-10-16 2011-01-19 ポーラ化成工業株式会社 皮膚になめらかさを与える皮膚外用剤
CN101606901B (zh) 2008-06-20 2012-11-07 赢创德固赛特种化学(上海)有限公司 高含水量唇膏及其制备方法
FR2943896B1 (fr) * 2009-04-01 2012-03-02 Oreal "roll-on" a forte teneur en acide salicylique.
CN102648892A (zh) * 2012-05-02 2012-08-29 广州雅纯化妆品制造有限公司 一种补水保湿霜
CN104853717B (zh) * 2012-12-24 2019-04-16 荷兰联合利华有限公司 化妆品组合物
WO2014101699A1 (en) 2012-12-24 2014-07-03 Unilever N.V. Use of cosmetic composition
US9713587B2 (en) * 2014-09-26 2017-07-25 The Procter & Gamble Company Methods for smoothing wrinkles and skin texture imperfections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818105A (en) * 1971-08-23 1974-06-18 Exxon Research Engineering Co Composition and process for lubricating the skin
US5525344A (en) * 1995-01-03 1996-06-11 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Clear cold cream cosmetic compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0117496A1 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535373B2 (en) 2004-03-03 2013-09-17 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US10966823B2 (en) 2007-10-12 2021-04-06 Sorin Group Italia S.R.L. Expandable valve prosthesis with sealing mechanism
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11969341B2 (en) 2018-05-23 2024-04-30 Corcym S.R.L. Cardiac valve prosthesis

Also Published As

Publication number Publication date
CN1373654A (zh) 2002-10-09
WO2001017496A1 (en) 2001-03-15
JP2003508478A (ja) 2003-03-04
CA2381560A1 (en) 2001-03-15
BR0013874A (pt) 2002-05-14
MXPA02002608A (es) 2003-10-14
KR20020047153A (ko) 2002-06-21
AU7392900A (en) 2001-04-10

Similar Documents

Publication Publication Date Title
JP3888470B2 (ja) 乳化したペトロラタムを含有する皮膚保護組成物
US5736125A (en) Compositions containing copolymers as a thickening agent
ES2262314T3 (es) Composicion cosmetica de dos fases.
JP3608623B2 (ja) 化粧品組成物
HU228359B1 (en) Oil-in-water type liquid composition for topical use
EP1214050A1 (de) Feuchtigkeitsspendende creme zur herstellung des hautgleichgewichts
JP4827433B2 (ja) 水中油型乳化皮膚化粧料
US5728371A (en) Skin protection, fragrance enhancing and vitamin delivery composition
US5728372A (en) Skin protection, fragrance enhancing and vitamin delivery composition
JP2003003013A (ja) アルキル化多糖類からなる水中油型乳化剤組成物、及び該組成物を用いた化粧料
JPWO2020137785A1 (ja) レチノール含有水中油型乳化化粧料
JP4202019B2 (ja) 皮膚外用剤
JPH08208420A (ja) 付着を引き起こす脂質系を含有する化粧乳濁液
WO2002004004A1 (en) Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solidds and oils
JP3515154B2 (ja) 乳化化粧料
JP2000290459A (ja) アクリルターポリマーを具備する水中油型エマルジョン形態の組成物、及びその使用、特にその化粧的使用
JP3022541B1 (ja) 外用剤
JPH10265332A (ja) 水中油型乳化組成物
JP2004315421A (ja) 美白化粧料
CN106999408B (zh) 雪花膏组合物及其应用
DE60125781T2 (de) Kosmetische und/oder dermatologische zusammenzetung mit verbesserter feuchtigkeit, enthaltend ein vernetzendes polysiloxan
JP2004026748A (ja) 油中水型乳化化粧料
JP2004315463A (ja) 化粧料
JP3580712B2 (ja) 乳化組成物
JP3005219B1 (ja) 外用剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030128